Contribution of rpoB2 RNA polymerase β subunit gene to rifampin resistance in Nocardia species

被引:53
作者
Ishikawa, J
Chiba, K
Kurita, H
Satoh, H
机构
[1] Natl Inst Infect Dis, Dept Bioact Mol, Shinjuku Ku, Tokyo 1628640, Japan
[2] Toho Univ, Fac Sci, Dept Biomol Sci, Chiba 2748510, Japan
关键词
D O I
10.1128/AAC.50.4.1342-1346.2006
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Nocardia species are gram-positive environmental saprophytes, but some cause the infectious disease nocardiosis. The complete genomic sequence of Nocardia farcinica IFM 10152 has been determined, and analyses indicated the presence of two different RNA polymerase beta subunit genes, rpoB and rpoB2, in the genome (J. Ishikawa, A. Yamashita, Y. Mikami, Y. Hoshino, H. Kurita, K. Hotta, T. Shiba, and M. Hattori, Proc. Natl. Acad. Sci. USA 101:14925-14930, 2004). These genes share 88.8% identity at the nucleotide level. Moreover, comparison of their amino acid sequences with those of other bacterial RpoB proteins suggested that the nocardial RpoB protein is likely to be rifampin (RIF) sensitive, whereas RpoB2 protein contains substitutions at the RIF-binding region that are likely to confer RIF resistance. Southern analysis indicated that rpoB duplication is widespread in Nocardia species and is correlated with the RIF-resistant phenotype. The introduction of rpoB2 by using a newly developed Nocardia-Escherichia coli shuttle plasmid vector and transformation system conferred RIF resistance to Nocardia asteroides IFM 0319(T), which has neither RIF resistance nor rpoB duplication. Furthermore, unmarked rpoB2 deletion mutants of N. farcinica IFM 10152 showed no significant resistance to RIF. These results indicated the contribution of rpoB2 to RIF resistance in Nocardia species. Since this is the first example of genetic engineering of the Nocardia genome, we believe that this study, as well as our determination of the N. farcinica genome sequence, will be a landmark in Nocardia genetics.
引用
收藏
页码:1342 / 1346
页数:5
相关论文
共 24 条
[1]   Monooxygenase-like sequence of a Rhodococcus equi gene conferring increased resistance to rifampin by inactivating this antibiotic [J].
Andersen, SJ ;
Quan, S ;
Gowan, B ;
Dabbs, ER .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (01) :218-221
[2]   NUCLEOTIDE-SEQUENCES ENCODING AND PROMOTING EXPRESSION OF 3 ANTIBIOTIC-RESISTANCE GENES INDIGENOUS TO STREPTOMYCES [J].
BIBB, MJ ;
BIBB, MJ ;
WARD, JM ;
COHEN, SN .
MOLECULAR & GENERAL GENETICS, 1985, 199 (01) :26-36
[3]   Activation of antibiotic biosynthesis by specified mutations in the rpoB gene (encoding the RNA polymerase β subunit) of Streptomyces lividans [J].
Hu, HF ;
Zhang, Q ;
Ochi, K .
JOURNAL OF BACTERIOLOGY, 2002, 184 (14) :3984-3991
[4]   RNA polymerase mutation activates the production of a dormant antibiotic 3,3′-neotrehalosadiamine via an autoinduction mechanism in Bacillus subtilis [J].
Inaoka, T ;
Takahashi, K ;
Yada, H ;
Yoshida, M ;
Ochi, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (05) :3885-3892
[5]   The complete genomic sequence of Nocardia farcinica IFM 10152 [J].
Ishikawa, J ;
Yamashita, A ;
Mikami, Y ;
Hoshino, Y ;
Kurita, H ;
Hotta, K ;
Shiba, T ;
Hattori, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (41) :14925-14930
[6]  
Ishikawa J, 2000, ACTINOMYCETOLOGICA, V14, P1, DOI 10.3209/saj.14_1
[7]   Nocardial infections in Japan from 1992 to 2001, including the first report of infection by Nocardia transvalensis [J].
Kageyama A. ;
Yazawa K. ;
Ishikawa J. ;
Hotta K. ;
Nishimura K. ;
Mikami Y. .
European Journal of Epidemiology, 2004, 19 (4) :383-389
[8]   INSERTIONAL MUTAGENESIS AND ILLEGITIMATE RECOMBINATION IN MYCOBACTERIA [J].
KALPANA, GV ;
BLOOM, BR ;
JACOBS, WR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (12) :5433-5437
[9]   PLASMID PROFILES OF MYCOBACTERIUM-FORTUITUM COMPLEX ISOLATES [J].
LABIDI, A ;
DAUGUET, C ;
GOH, KS ;
DAVID, HL .
CURRENT MICROBIOLOGY, 1984, 11 (04) :235-240
[10]   Effect of rpoB mutations conferring rifampin resistance on fitness of Mycobacterium tuberculosis [J].
Mariam, DH ;
Mengistu, Y ;
Hoffner, SE ;
Andersson, DI .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (04) :1289-1294